These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 25643053)

  • 1. Upper limb strength and function changes during a one-year follow-up in non-ambulant patients with Duchenne Muscular Dystrophy: an observational multicenter trial.
    Seferian AM; Moraux A; Annoussamy M; Canal A; Decostre V; Diebate O; Le Moing AG; Gidaro T; Deconinck N; Van Parys F; Vereecke W; Wittevrongel S; Mayer M; Maincent K; Desguerre I; Thémar-Noël C; Cuisset JM; Tiffreau V; Denis S; Jousten V; Quijano-Roy S; Voit T; Hogrel JY; Servais L
    PLoS One; 2015; 10(2):e0113999. PubMed ID: 25643053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innovative methods to assess upper limb strength and function in non-ambulant Duchenne patients.
    Servais L; Deconinck N; Moraux A; Benali M; Canal A; Van Parys F; Vereecke W; Wittevrongel S; Mayer M; Desguerre I; Maincent K; Themar-Noel C; Quijano-Roy S; Serari N; Voit T; Hogrel JY
    Neuromuscul Disord; 2013 Feb; 23(2):139-48. PubMed ID: 23219352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory and upper limb function as outcome measures in ambulant and non-ambulant subjects with Duchenne muscular dystrophy: A prospective multicentre study.
    Ricotti V; Selby V; Ridout D; Domingos J; Decostre V; Mayhew A; Eagle M; Butler J; Guglieri M; Van der Holst M; Jansen M; Verschuuren JJGM; de Groot IJM; Niks EH; Servais L; Straub V; Voit T; Hogrel JY; Muntoni F
    Neuromuscul Disord; 2019 Apr; 29(4):261-268. PubMed ID: 30852071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upper limb evaluation and one-year follow up of non-ambulant patients with spinal muscular atrophy: an observational multicenter trial.
    Seferian AM; Moraux A; Canal A; Decostre V; Diebate O; Le Moing AG; Gidaro T; Deconinck N; Van Parys F; Vereecke W; Wittevrongel S; Annoussamy M; Mayer M; Maincent K; Cuisset JM; Tiffreau V; Denis S; Jousten V; Quijano-Roy S; Voit T; Hogrel JY; Servais L
    PLoS One; 2015; 10(4):e0121799. PubMed ID: 25861036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Movement Monitor Based on Magneto-Inertial Sensors for Non-Ambulant Patients with Duchenne Muscular Dystrophy: A Pilot Study in Controlled Environment.
    Le Moing AG; Seferian AM; Moraux A; Annoussamy M; Dorveaux E; Gasnier E; Hogrel JY; Voit T; Vissière D; Servais L
    PLoS One; 2016; 11(6):e0156696. PubMed ID: 27271157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upper Limb Evaluation in Duchenne Muscular Dystrophy: Fat-Water Quantification by MRI, Muscle Force and Function Define Endpoints for Clinical Trials.
    Ricotti V; Evans MR; Sinclair CD; Butler JW; Ridout DA; Hogrel JY; Emira A; Morrow JM; Reilly MM; Hanna MG; Janiczek RL; Matthews PM; Yousry TA; Muntoni F; Thornton JS
    PLoS One; 2016; 11(9):e0162542. PubMed ID: 27649492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upper limb function in Duchenne muscular dystrophy: 24 month longitudinal data.
    Pane M; Coratti G; Brogna C; Mazzone ES; Mayhew A; Fanelli L; Messina S; D'Amico A; Catteruccia M; Scutifero M; Frosini S; Lanzillotta V; Colia G; Cavallaro F; Rolle E; De Sanctis R; Forcina N; Petillo R; Barp A; Gardani A; Pini A; Monaco G; D'Angelo MG; Zanin R; Vita GL; Bruno C; Mongini T; Ricci F; Pegoraro E; Bello L; Berardinelli A; Battini R; Sansone V; Albamonte E; Baranello G; Bertini E; Politano L; Sormani MP; Mercuri E
    PLoS One; 2018; 13(6):e0199223. PubMed ID: 29924848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits of glucocorticoids in non-ambulant boys/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test.
    Pane M; Fanelli L; Mazzone ES; Olivieri G; D'Amico A; Messina S; Scutifero M; Battini R; Petillo R; Frosini S; Sivo S; Vita GL; Bruno C; Mongini T; Pegoraro E; De Sanctis R; Gardani A; Berardinelli A; Lanzillotta V; Carlesi A; Viggiano E; Cavallaro F; Sframeli M; Bello L; Barp A; Bianco F; Bonfiglio S; Rolle E; Palermo C; D'Angelo G; Pini A; Iotti E; Gorni K; Baranello G; Bertini E; Politano L; Sormani MP; Mercuri E
    Neuromuscul Disord; 2015 Oct; 25(10):749-53. PubMed ID: 26248957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upper limb function in adults with Duchenne muscular dystrophy.
    Bartels B; Pangalila RF; Bergen MP; Cobben NA; Stam HJ; Roebroeck ME
    J Rehabil Med; 2011 Sep; 43(9):770-5. PubMed ID: 21826385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Performance of the Upper Limb scores correlate with pulmonary function test measures and Egen Klassifikation scores in Duchenne muscular dystrophy.
    Lee HN; Sawnani H; Horn PS; Rybalsky I; Relucio L; Wong BL
    Neuromuscul Disord; 2016; 26(4-5):264-71. PubMed ID: 27056113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship Between Hand Strength and Function in Duchenne Muscular Dystrophy and Spinal Muscular Atrophy: Implications for Clinical Trials.
    Decostre V; De Antonio M; Servais L; Hogrel JY
    J Neuromuscul Dis; 2024; 11(4):777-790. PubMed ID: 38788084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upper limb disease evolution in exon 53 skipping eligible patients with Duchenne muscular dystrophy.
    Lilien C; Reyngoudt H; Seferian AM; Gidaro T; Annoussamy M; Chê V; Decostre V; Ledoux I; Le Louër J; Guemas E; Muntoni F; Hogrel JY; Carlier PG; Servais L;
    Ann Clin Transl Neurol; 2021 Oct; 8(10):1938-1950. PubMed ID: 34453498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliability of the Performance of Upper Limb assessment in Duchenne muscular dystrophy.
    Pane M; Mazzone ES; Fanelli L; De Sanctis R; Bianco F; Sivo S; D'Amico A; Messina S; Battini R; Scutifero M; Petillo R; Frosini S; Scalise R; Vita G; Bruno C; Pedemonte M; Mongini T; Pegoraro E; Brustia F; Gardani A; Berardinelli A; Lanzillotta V; Viggiano E; Cavallaro F; Sframeli M; Bello L; Barp A; Bonfiglio S; Rolle E; Colia G; Catteruccia M; Palermo C; D'Angelo G; Pini A; Iotti E; Gorni K; Baranello G; Morandi L; Bertini E; Politano L; Sormani M; Mercuri E
    Neuromuscul Disord; 2014 Mar; 24(3):201-6. PubMed ID: 24440357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trial readiness in non-ambulatory boys and men with duchenne muscular dystrophy: MDA-DMD network follow-up.
    Connolly AM; Florence JM; Zaidman CM; Golumbek PT; Mendell JR; Flanigan KM; Karachunski PI; Day JW; McDonald CM; Darras BT; Kang PB; Siener CA; Gadeken RK; Anand P; Schierbecker JR; Malkus EC; Lowes LP; Alfano LN; Johnson L; Nicorici A; Kelecic JM; Quigley J; Pasternak AE; Miller JP;
    Muscle Nerve; 2016 Oct; 54(4):681-9. PubMed ID: 26930423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upper extremity outcome measures for collagen VI-related myopathy and LAMA2-related muscular dystrophy.
    Bendixen RM; Butrum J; Jain MS; Parks R; Hodsdon B; Nichols C; Hsia M; Nelson L; Keller KC; McGuire M; Elliott JS; Linton MM; Arveson IC; Tounkara F; Vasavada R; Harnett E; Punjabi M; Donkervoort S; Dastgir J; Leach ME; Rutkowski A; Waite M; Collins J; Bönnemann CG; Meilleur KG
    Neuromuscul Disord; 2017 Mar; 27(3):278-285. PubMed ID: 28087121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manual ability and upper limb performance in nonambulatory stage of Duchenne muscular dystrophy.
    Demir G; Bulut N; Yılmaz Ö; Karaduman A; Alemdaroğlu-Gürbüz İ
    Arch Pediatr; 2020 Aug; 27(6):304-309. PubMed ID: 32718814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal functional and NMR assessment of upper limbs in Duchenne muscular dystrophy.
    Hogrel JY; Wary C; Moraux A; Azzabou N; Decostre V; Ollivier G; Canal A; Lilien C; Ledoux I; Annoussamy M; Reguiba N; Gidaro T; Le Moing AG; Cardas R; Voit T; Carlier PG; Servais L
    Neurology; 2016 Mar; 86(11):1022-30. PubMed ID: 26888987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards a short questionnaire for stepwise assessment of upper limb function, pain and stiffness in Duchenne muscular dystrophy.
    Janssen MMHP; Geurts ACH; de Groot IJM
    Disabil Rehabil; 2018 Apr; 40(7):842-847. PubMed ID: 28084836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of pulmonary function in 10-18 year old patients with Duchenne muscular dystrophy.
    Meier T; Rummey C; Leinonen M; Spagnolo P; Mayer OH; Buyse GM;
    Neuromuscul Disord; 2017 Apr; 27(4):307-314. PubMed ID: 28189481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study.
    McDonald CM; Henricson EK; Abresch RT; Duong T; Joyce NC; Hu F; Clemens PR; Hoffman EP; Cnaan A; Gordish-Dressman H;
    Lancet; 2018 Feb; 391(10119):451-461. PubMed ID: 29174484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.